AETHLON MEDICAL INC
AEMDStock
$0.67−94.04%52W
Market Cap$1.79M
P/E—
Div yield—
Beta1.44
Price Chart
Favorite Metrics
Price vs S&P 500 (26W)-84.56%
Price vs S&P 500 (4W)-65.35%
VGM Score54.58
Market Capitalization$1.79M
Earnings Surprise History
Q4 26-1.49est. -2.06
Analyst Recommendations
Apr 2026
May 2026
Jun 2026
Jul 2026
2.29
2.29
2.29
2.29
Industry Peers — Surgical & Medical Instruments(141)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
AEMDAETHLON MEDICAL INC | — | A | F | $0.67 |
| SYKStryker Corporation | C | C | D | $331.20 |
| MMM3M Company | C | F | B | $161.77 |
| BSXBoston Scientific Corp. | C | B | F | $44.62 |
| MDLNMedline Inc. Class A common stock | C | D | D | $41.11 |
| BDXBecton, Dickinson and Co. | B | C | B | $159.93 |
| DXCMDexCom, Inc. | C | B | C | $77.98 |
| RMDResMed Inc. | C | B | D | $202.76 |
| WSTWest Pharmaceutical Services, Inc. | D | C | A | $362.44 |
| SOLVSolventum Corporation | C | D | B | $81.70 |
| PENPenumbra, Inc. | F | C | B | $319.60 |
About
Aethlon Medical is a medical device company developing the Hemopurifier, a clinical-stage therapeutic device designed to remove cancer cells and life-threatening viruses from the circulatory system. The platform addresses significant unmet needs in cancer treatment and biodefense through novel blood purification technology.